511
Participants
Start Date
April 30, 2009
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
Regadenoson
IV
Placebo
IV
New York
Springfield Gardens
Indiana
Duncansville
Tyrone
Wyomissing
Newark
Wilmington
Spartanburg
Charleston
Winter Park
Orlando
Miami
Fort Lauderdale
Trinity
Anniston
Knoxville
Ellijay
Springfield
Detroit
Flint
Minneapolis
Chicago
Little Rock
Oklahoma City
Houston
Houston
Sugar Grove
Los Angeles
Los Angeles
Bell Gardens
Mission Viejo
Santa Ana
Fullerton
Garden Grove
Oakland
Roseville
Bend
Auburn
Ridgewood
Somerset
Lead Sponsor
Astellas Pharma Inc
INDUSTRY